Trials / Sponsors / P. Herzen Moscow Oncology Research Institute
P. Herzen Moscow Oncology Research Institute
Other Government · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric Gastric Cancer (GC), Siewert Type III Adenocarcinoma of Esophagogastric Junction, Siewert Type II Adenocarcinoma of Esophagogastric Junction | — | 2025-01-01 |
| Unknown | Postoperative Morbidity and Mortality After Gastric Cancer Surgery Gastric Cancer, Siewert Type III Adenocarcinoma of Esophagogastric Junction, Stomach Cancer | — | 2024-03-18 |
| Completed | Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery Esophageal Cancer, Oesophageal Cancer, Siewert Type I Adenocarcinoma of Esophagogastric Junction | — | 2024-03-18 |
| Completed | Neoadjuvant FOLFOX Chemotherapy for Colon Cancer: Long-Term Chemotherapy-Induced Peripheral Neuropathy and Imp Chemotherapy Induced Peripheral Neuropathy (CIPN) | — | 2021-03-19 |
| Active Not Recruiting | Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer Gastric Cancer (GC), Next-generation Sequencing, Molecular Analysis | — | 2020-01-10 |